Picture of Bioelife logo

LITH Bioelife Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual income statement for Bioelife, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2014
December 31st
2015
December 31st
2016
December 31st
2017
December 31st
2018
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue00000
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses0.4640.0430.1040.125-0.602
Operating Profit-0.464-0.043-0.104-0.1250.602
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-0.498-0.082-0.21-0.247-0.337
Net Income After Taxes-0.498-0.082-0.21-0.247-0.337
Net Income Before Extraordinary Items
Net Income-0.498-0.082-0.21-0.247-0.337
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.498-0.082-0.21-0.247-0.337
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.442-0.053-0.092-0.101-0.389
Dividends per Share

Or unlock with your email

Or unlock with your email